BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Staging
69 results:

  • 1. Update on FDG-PET in pediatric lymphoma.
    Kurch L; Kluge R
    Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):58-69. PubMed ID: 38587361
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long non-coding RNA small nucleolar RNA host gene 29 drives chronic myeloid leukemia progression via microRNA-483-3p/Casitas B-lineage lymphoma axis-mediated activation of the phosphoinositide 3-kinase/Akt pathway.
    Feng X; Yang L; Liu X; Liu M; Liu L; Liu J; Luo J
    Med Oncol; 2024 Jan; 41(2):60. PubMed ID: 38252204
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic Leukemia.
    Marinelli LM; Romain JT; Ehman W; Ortega V; Velagaleti G; Gibbons TF; Nazario-Toole A; Holmes AR
    Cancer Genet; 2023 Aug; 276-277():43-47. PubMed ID: 37480761
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Enhancing information on stage at diagnosis for childhood cancer in Africa.
    Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma].
    Dourthe ME; Simonin M; Rigaud C; Haouy S; Montravers F; Ducou Le Pointe H; Garnier N; Minard-Colin V; Jo Molina T; Boudjemaa S; Leblanc T; Landman-Parker J
    Bull Cancer; 2023 Sep; 110(9):968-977. PubMed ID: 37062647
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Paediatric pre-B acute lymphoblastic leukaemia-derived exosomes regulate immune function in human T cells.
    Gholipour E; Kahroba H; Soltani N; Samadi P; Sarvarian P; Vakili-Samiani S; Hosein Pour Feizi AA; Soltani-Zangbar MS; Baghersalimi A; Darbandi B; Movassaghpour A; Talebi M; Motavalli R; Mehdizadeh A; Kazemi A; Yousefi M
    J Cell Mol Med; 2022 Aug; 26(16):4566-4576. PubMed ID: 35822529
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Lymphoblastic lymphoma: a Concise Review.
    Intermesoli T; Weber A; Leoncin M; Frison L; Skert C; Bassan R
    Curr Oncol Rep; 2022 Jan; 24(1):1-12. PubMed ID: 35059993
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Outcomes of children and young adults with T-cell acute lymphoblastic leukemia/lymphoma who present in critical status.
    Wayne NJ; Li Y; Chung P; Coffan K; Rheingold SR
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29457. PubMed ID: 34997812
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [lymphoma in children and adolescents].
    Sorge I; Georgi TW; Hirsch FW
    Radiologe; 2021 Jul; 61(7):611-618. PubMed ID: 34160645
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Raman and quantitative phase imaging allow morpho-molecular recognition of malignancy and stages of B-cell acute lymphoblastic leukemia.
    Paidi SK; Raj P; Bordett R; Zhang C; Karandikar SH; Pandey R; Barman I
    Biosens Bioelectron; 2021 Oct; 190():113403. PubMed ID: 34130086
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-phl-C1 trial.
    Kurch L; Mauz-Körholz C; Fosså A; Georgi TW; Kluge R; Bartelt JM; Kunze C; Wohlgemuth WA; Pelz T; Vordermark D; Plößl S; Hasenclever D; Sabri O; Landman-Parker J; Wallace WH; Karlen J; Fernández-Teijeiro A; Cepelova M; Klekawka T; Løndalen AM; Steiner D; Krombach G; Attarbaschi A; Hoffmann M; Ceppi F; Pears J; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Daw S; Körholz D; Stoevesandt D
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28903. PubMed ID: 33538093
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Clinical analysis of a modified LMB89 Group C regimen in the treatment of pediatric high-risk Burkitt lymphoma].
    Zhang M; Jin L; Yang J; Duan YL; Huang S; Zhou CJ; Zhang YH
    Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):633-638. PubMed ID: 31495128
    [No Abstract]    [Full Text] [Related]  

  • 13. Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial.
    Kurch L; Hasenclever D; Kluge R; Georgi T; Tchavdarova L; Golombeck M; Sabri O; Eggert A; Brenner W; Sykora KW; Bengel FM; Rossig C; Körholz D; Schäfers M; Feuchtinger T; Bartenstein P; Ammann RA; Krause T; Urban C; Aigner R; Gattenlöhner S; Klapper W; Mauz-Körholz C
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27539. PubMed ID: 30426671
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Value of CD, MPO, Ki-67 and C-MYC Positive Rate in the Pathological Tissues and C-MYC Gene of Patients with T-LBL/ALL for Predicting Prognosis].
    Wu Y; Tang HY; Ding YY; Pan XQ; Tan CM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):110-115. PubMed ID: 29397827
    [TBL] [Abstract] [Full Text] [Related]  

  • 15.
    Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Significance of CXCL12/CXCR4 expression in T-lymphoblastic lymphoma/leukemia].
    Yu ZZ; Xi YF; Li J; Bai WQ; Gao N; Bu P
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):838-843. PubMed ID: 28056298
    [No Abstract]    [Full Text] [Related]  

  • 17. [Reseach Progress of Ki-67 in Acute Myeloid Leukemia-Review].
    Wang M; Wang LR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1264-8. PubMed ID: 27531813
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Expression of CD30 in Diffuse Large B Cell lymphoma and Its Clinical Significance].
    Zhao YF; Qian SX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):717-21. PubMed ID: 27342497
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [LMB chemotherapy for mature B-cell neoplasms in children: a single-center experience].
    Osumi T; Mori T; Shioda Y; Kiyotani C; Terashima K; Kato M; Tomizawa D; Ohki K; Kiyokawa N; Iwafuchi H; Yoshioka T; Nakazawa A; Matsumoto K
    Rinsho Ketsueki; 2016 Mar; 57(3):346-52. PubMed ID: 27076248
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Is there an increased risk of metabolic syndrome among childhood acute lymphoblastic leukemia survivors? A developing country experience.
    Mohapatra S; Bansal D; Bhalla AK; Verma Attri S; Sachdeva N; Trehan A; Marwaha RK
    Pediatr Hematol Oncol; 2016 Mar; 33(2):136-49. PubMed ID: 26984439
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.